Skip to main content

Table 9 Female results by disease state for GPC5, rs10492503. Significance for the PP case subgroup is suggestive only as cell counts fell below the minimum required for chi-squared testing (n < 5)

From: An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population

 GPC5rs10492503
PolymorphismGenotypesAlleles
GroupAA (%)AT (%)TT (%)pA (%)T (%)POR (95% CI)
Female MS case
PP (n= 35)17 (48.6)16 (45.7)2 (5.7)0.335850 (71.4)20 (28.6)0.48470.81
SP (n= 40)9 (22.5)25 (62.5)6 (15.0)0.008743 (53.8)37 (46.2)0.0301.75
RR (n= 85)27 (31.8)36 (42.4)22 (25.9)0.024590 (52.9)80 (47.1)0.00321.81
Total control (n= 132)64 (48.5)49 (37.1)19 (14.4)177 (67.1)87 (32.9)
HapMap CEU (%)38.351.710 64.235.8  
\